Tamara Norambuena
Brazilian Cristália acquired the Argentine IMA
The Cristália group acquired the Argentine pharmaceutical company specialized in oncology, IMA Laboratorios. For over u$s10 million. In this way, the Zaffaroni family and the Blanco family detached themselves from the visionary enterprise founded in 1962, whose origin was the Argentine Metallurgic Industry (IMA).
The Cristália group acquired the Argentine pharmaceutical...